These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 18390817)

  • 21. Complementary mutations in seipin gene in a patient with Berardinelli-Seip congenital lipodystrophy and dystonia: phenotype variability suggests multiple roles of seipin gene.
    Wu YR; Hung SI; Chang YC; Chen ST; Lin YL; Chung WH
    J Neurol Neurosurg Psychiatry; 2009 Oct; 80(10):1180-1. PubMed ID: 19762912
    [No Abstract]   [Full Text] [Related]  

  • 22. A Novel Generalized Lipodystrophy-Associated Progeroid Syndrome Due to Recurrent Heterozygous LMNA p.T10I Mutation.
    Hussain I; Patni N; Ueda M; Sorkina E; Valerio CM; Cochran E; Brown RJ; Peeden J; Tikhonovich Y; Tiulpakov A; Stender SRS; Klouda E; Tayeh MK; Innis JW; Meyer A; Lal P; Godoy-Matos AF; Teles MG; Adams-Huet B; Rader DJ; Hegele RA; Oral EA; Garg A
    J Clin Endocrinol Metab; 2018 Mar; 103(3):1005-1014. PubMed ID: 29267953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early infantile cardiomyopathy and liver disease: a multisystemic disorder caused by congenital lipodystrophy.
    Debray FG; Baguette C; Colinet S; Van Maldergem L; Verellen-Dumouin C
    Mol Genet Metab; 2013 Jun; 109(2):227-9. PubMed ID: 23647707
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The worldwide mutational landscape of Berardinelli-Seip congenital lipodystrophy.
    Craveiro Sarmento AS; Ferreira LC; Lima JG; de Azevedo Medeiros LB; Barbosa Cunha PT; Agnez-Lima LF; Galvão Ururahy MA; de Melo Campos JTA
    Mutat Res Rev Mutat Res; 2019; 781():30-52. PubMed ID: 31416577
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of a short human seipin/BSCL2 isoform in mouse adipose tissue results in mild lipodystrophy.
    Cui X; Wang Y; Meng L; Fei W; Deng J; Xu G; Peng X; Ju S; Zhang L; Liu G; Zhao L; Yang H
    Am J Physiol Endocrinol Metab; 2012 Mar; 302(6):E705-13. PubMed ID: 22234369
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Type 2 Congenital Generalized Lipodystrophy: The Diagnosis is in Your Hands.
    Montenegro RM; Fernandes VO; Penaforte Saboia JG; Montenegro APDR; Lima JG
    J Pediatr; 2019 Apr; 207():257-257.e1. PubMed ID: 30579587
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical classification and treatment of congenital and acquired lipodystrophy.
    Chan JL; Oral EA
    Endocr Pract; 2010; 16(2):310-23. PubMed ID: 20061300
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Child with Lipemic Sample: Berardinelli-Seip Congenital Lipodystrophy.
    -Ain QU; Sheikh W; Shahzad N
    J Coll Physicians Surg Pak; 2020 Feb; 30(2):225. PubMed ID: 32036838
    [No Abstract]   [Full Text] [Related]  

  • 29. Rare case of congenital generalized lipodystrophy type 1.
    Shyam Sundar CM; Subrahmanyam KAV
    Indian J Med Res; 2020 Nov; 152(Suppl 1):S181-S182. PubMed ID: 35345194
    [No Abstract]   [Full Text] [Related]  

  • 30. Further delineation of AGPAT2 and BSCL2 related congenital generalized lipodystrophy in young infants.
    Liu Y; Li D; Ding Y; Kang L; Jin Y; Song J; Li H; Yang Y
    Eur J Med Genet; 2019 Sep; 62(9):103542. PubMed ID: 30266686
    [TBL] [Abstract][Full Text] [Related]  

  • 31. W(h)ither metreleptin for lipodystrophy and the metabolic syndrome?
    Mantzoros CS
    Endocr Pract; 2010; 16(2):162-6. PubMed ID: 20350904
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical and molecular characterization of two Chinese patients with Type 2 congenital generalized lipodystrophy.
    Chen R; Yuan X; Wang J; Zhang Y
    Gene; 2017 Dec; 637():57-62. PubMed ID: 28916377
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A new laminopathy caused by an Arg133/Leu mutation in
    Wang Z; Dong Y; Yang J; He Y; Lin X; Wu F; Li H; Zheng F
    Adipocyte; 2019 Dec; 8(1):280-291. PubMed ID: 31293201
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heterozygous CAV1 frameshift mutations (MIM 601047) in patients with atypical partial lipodystrophy and hypertriglyceridemia.
    Cao H; Alston L; Ruschman J; Hegele RA
    Lipids Health Dis; 2008 Jan; 7():3. PubMed ID: 18237401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. First metreleptin treatment for generalized lipodystrophy in Turkey.
    Simsir IY; Yurekli BS; Saygili F; Altay C; Akinci B
    Diabetes Obes Metab; 2017 Feb; 19(2):299-301. PubMed ID: 27717125
    [No Abstract]   [Full Text] [Related]  

  • 36. Eating behaviour in contrasting adiposity phenotypes: Monogenic obesity and congenital generalized lipodystrophy.
    Santos JL; Cortés VA
    Obes Rev; 2021 Jan; 22(1):e13114. PubMed ID: 33030294
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interaction of cavin-1/PTRF leucine zipper domain 2 and its congenital generalized lipodystrophy mutant with model membranes.
    Mohapatra A; Lokappa SB; Chaudhary N
    Biochem Biophys Res Commun; 2020 Jan; 521(3):732-738. PubMed ID: 31706570
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Postmortem Findings in a Young Man With Congenital Generalized Lipodystrophy, Type 4 Due to CAVIN1 Mutations.
    Patni N; Vuitch F; Garg A
    J Clin Endocrinol Metab; 2019 Mar; 104(3):957-960. PubMed ID: 30476128
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel BSCL2 gene mutation E189X in Chinese congenital generalized lipodystrophy child with early onset diabetes mellitus.
    Jin J; Cao L; Zhao Z; Shen S; Kiess W; Zhi D; Ye R; Cheng R; Chen L; Yang Y; Luo F
    Eur J Endocrinol; 2007 Dec; 157(6):783-7. PubMed ID: 18057387
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Whole exome sequencing identifies de novo heterozygous CAV1 mutations associated with a novel neonatal onset lipodystrophy syndrome.
    Garg A; Kircher M; Del Campo M; Amato RS; Agarwal AK;
    Am J Med Genet A; 2015 Aug; 167A(8):1796-806. PubMed ID: 25898808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.